OPEN Foundation

Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

51qUsAI+YsL._SX327_BO1,204,203,200_Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception―changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By the 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was motivated by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing and the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use―under the guidance of a trained provider―psychedelic substances for better physical and mental health.

Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments [fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][2 delen], door Thomas B. Roberts & Michael J. Winkelman, Praeger Perspectives reeks, Praeger, 728 pagina’s.

Koop dit boek via bookdepository.com en steun daarmee Stichting OPEN (deel 1)

Koop dit boek via bookdepository.com en steun daarmee Stichting OPEN (deel 2)[/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

OPEN Foundation

Join ICPR 2022 Online!

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. Get your ICPR 2022 livestream ticket today and use the code OPENLIVE30 at checkout for a €30 discount.

Learn More

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.